At the end of Q3 2024, 29 institutions reported holding Alaunos Therapeutics Inc. (TCRT) in their 13F filings, up 26 from Q2 2024. 28 opened new positions and 2 sold out. The largest holders were MSD Partners, L.P. ($325K), Vanguard Group Inc. ($149K) and BlackRock, Inc. ($72K).
Company
Alaunos Therapeutics Inc.
CUSIP
98973P309
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
Institutions
Total Value
New Positions
28
$551K
Exits
2
$8
All 13F filers, Q2 2024 → Q3 2024: 169,834 shares bought and 35 shares sold, net +169,799 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.